top of page
Publications 
  1. Kim HJ, Kim KW, Cha DH, Yoo J, Kim EH, et al. Precancerous cells initiate glioblastoma evolution and contribute to intratumoral heterogeneity. Cancer Discov. 2025 Apr 16. doi: 10.1158/2159-8290.CD-24-0234. Epub ahead of print.

    Li X, Kim HJ, Yoo J, Lee Y, Nam CH, Park J, et al. Distant origin of glioblastoma recurrence: neural stem cells in the subventricular zone serve as a source of tumor reconstruction after primary resection. Molecular Cancer. 2025;24(1):64.

  2. Ryu H, Li X, Lee TH, Kim TM, Choi SH, Park CK, et al. Distribution and failure patterns of primary central nervous system lymphoma related to the hippocampus: implications for hippocampal avoidance irradiation. J Neurooncol. 2025.

  3. Wee CW, Lee JH, Lee HI, Kim J, Chang JH, Kang SG, et al. To Use or Not to Use: Temozolomide in Elderly Patients with IDH Wild-type MGMT Promoter Unmethylated Glioblastoma Treated with Radiotherapy. Cancer Res Treat. 2024.

  4. Son J, Kim JS, Li X, Park H, Yoon E, Jeon S-R, et al. Development of a novel tool for high-precision focal irradiation using a clinical brachytherapy system. Physica Medica. 2024;127:104825.

  5. Ye Kahng J, Kang BH, Lee ST, Hong Choi S, Min Kim T, Park CK, et al. Clinicogenetic characteristics and the effect of radiation on the neural stem cell niche in subventricular zone-contacting glioblastoma. Radiother Oncol. 2023:109800.

  6. Ryu H, Lee JH. Excluding prepontine cistern from whole ventricle radiotherapy target volume in localized germinoma. Radiat Oncol J. 2023;41(1):48-57.

  7. Lee TH, Kang BH, Kim HJ, Wu HG, Lee JH. Predictors of Post-Chemoradiotherapy Pulmonary Complication in Locally Advanced Non-Small Cell Lung Cancer. Cancer Res Treat. 2023.

  8. Kim JS, Lee JH, Jeon SR, Kim Y, Jeon SH, Wu HG. Identification of Genes Involved in EGF-induced Apoptosis Using CRISPR/Cas9 Knockout Screening: Implications for Novel Therapeutic Targets in EGFR-Overexpressing Cancers. Cancer Res Treat. 2023;55(3):737-45.

  9. Kim D, Chang WI, Byun HK, Kim IA, Cho J, Lee JH, et al. Dose–response relationship in patients with newly diagnosed atypical meningioma treated with adjuvant radiotherapy. Journal of Neuro-Oncology. 2023;161(2):329-37.

  10. Lee JH, Wee CW. Treatment of Adult Gliomas: A Current Update. Brain Neurorehabil. 2022;15(3).

  11. Lee JH, Jeon SH, Park CK, Park SH, Yoon HI, Chang JH, et al. The Role of Postoperative Radiotherapy in Intracranial Solitary Fibrous Tumor/Hemangiopericytoma: A Multi-institutional Retrospective Study (KROG 18-11). Cancer Res Treat. 2022;54(1):65-74.

  12. Lee HI, Lee J, Lee JH, Wu HG, Kim JH, Kim Y, et al. Evaluation of Optimal Assessment Schedules for Surveillance After Definitive Locoregional Treatment of Locally Advanced Head and Neck Cancer: A Retrospective Cohort Study With Parametric Modeling of Event-Free Survival. JAMA Otolaryngol Head Neck Surg. 2022.

  13. Kim D, Choi JY, Hong KT, Kang HJ, Kim IH, Lee JH. Long-term outcomes of low-dose radiotherapy in Kasabach-Merritt syndrome. Radiat Oncol J. 2022;40(1):45-52.

  14. Kang BH, Li X, Son J, Song C, Kang HC, Kim HJ, et al. Prediction and clinical impact of delayed lymphopenia after chemoradiotherapy in locally advanced non-small cell lung cancer. Front Oncol. 2022;12:891221.

  15. Chang WI, Kim IH, Choi SH, Kim TM, Lee ST, Won JK, et al. Risk Stratification to Define the Role of Radiotherapy for Benign and Atypical Meningioma: A Recursive Partitioning Analysis. Neurosurgery. 2022;90(5):619-26.

  16. Lee JH, Eom KY, Phi JH, Park CK, Kim SK, Cho BK, et al. Long-Term Outcomes and Sequelae Analysis of Intracranial Germinoma: Need to Reduce the Extended-Field Radiotherapy Volume and Dose to Minimize Late Sequelae. Cancer Res Treat. 2021;53(4):983-90.

  17. Kim H, Lee JH, Kim HJ, Park CM, Wu HG, Goo JM. Extended application of a CT-based artificial intelligence prognostication model in patients with primary lung cancer undergoing stereotactic ablative radiotherapy. Radiother Oncol. 2021;165:166-73.

  18. Lee JH, Kang BH, Song C, Kang SB, Lee HS, Lee KW, et al. Microsatellite Instability Correlated Inflammatory Markers and their Prognostic Value in the Rectal Cancer Following Neoadjuvant Chemoradiotherapy: A Hypothesis-generating Study. In Vivo. 2020;34(4):2119-26.

  19. Kim JS, Lee JH. Exceptional response to radiotherapy in unresectable pleuropulmonary blastoma of a child. Radiat Oncol J. 2020;38(2):148-50.

  20. Lee JH, Song C, Kang SB, Lee HS, Lee KW, Kim JS. Predicting Pathological Complete Regression with Haematological Markers During Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. Anticancer Res. 2018;38(12):6905-10.

bottom of page